Non-Hodgkin Lymphomas

Aggressive Lymphomas

• Burkitt Lymphoma: Revisiting the Pathogenesis of a Virus-Associated Malignancy (2007)
• Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways (2007)
• Antibody Therapy in Aggressive Lymphomas (2007)
• Molecular Signatures Define New Rational Treatment in Large B-Cell Lymphomas (2007)
• Monoclonal Antibodies for B-Cell Lymphomas: Rituximab and Beyond (2007)
• Vaccine Therapy for B-Cell Lymphomas: Next-Generation Strategies (2007)
• Diffuse Large B-Cell Lymphoma: Risk Stratification and Management of Relapsed Disease (2005)

General

• Should Adolescents with NHL Be Treated as Old Children or Young Adults? (2007)
• Diagnosis and Treatment of Childhood Non-Hodgkin Lymphoma (2007)
• Optimal Use of Prognostic Factors in Non-Hodgkin Lymphoma (2006)
  
• Multimodality Therapies and Optimal Schedule of Antibodies: Rituximab in Lymphoma as an Example (2005)
• Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy (2005)
• Targeting CD20 in Follicular NHL: Novel Anti-CD20 Therapies, Antibody Engineering, and the Use of Radioimmunoconjugates (2005)

Indolent Lymphomas

• Clinical Features, Prognosis and Treatment of Follicular Lymphoma (2007)
• Follicular NHL: From Antibodies and Vaccines to Graft-versus-Lymphoma Effects (2007)
• Controversies in Follicular Lymphoma: "Who, What, When, Where, and Why?" (Not Necessarily in That Order!) (2006)
• Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas (2005)
• Clinical Presentation and Management of Marginal Zone Lymphomas (2005)
• Biology and Management of Histologic Transformation of Indolent Lymphoma (2005)

Other

• The Biology of the Germinal Center (2007)
• An Update on Therapy of Primary Central Nervous System Lymphoma (2006)
• Biology and Treatment of Epstein-Barr Virus-Associated Non-Hodgkin Lymphomas (2005)
  

T-cell Lymphomas

• Engineering Antitumor Immunity by T-Cell Adoptive Immunotherapy (2007)
  
• Pathobiology of Peripheral T-cell Lymphomas (2006)
• Primary Cutaneous T-Cell Lymphomas (2006)
• Therapy of Peripheral T/NK Neoplasms (2006)
• Aggressive Peripheral T-Cell Lymphomas (Specified and Unspecified Types) (2005)